원발성 간암 환자의 혈청 Insulin-like Growth Factor Binding Proteins(IGFBPs) 양상
Serum Insulin-like Growth Factor Binding Proteins Profiles in Hepatocelllular Carcinoma
대한암학회지 1995년 27권 2호 p.238 ~ 246
이대열, 김대곤, 박근영,
소속 상세정보
이대열 ( )
전북대학교
김대곤 ( )
전북대학교
박근영 ( )
전북대학교
KMID : 0360319950270020238
Abstract
Recent findings have indicated that insulin-like growth factors(IGF-I &-Ⅱ) and it's binding proteins(IGFBPs) may play a role in neoplasia. Hepatoma is a common malignancy in this country and the liver is probably the source of most circulating
IGFs and
IGFBP-3.
We have studied serum IGFBPs pattern in hepatoma(n=20) and liver cirrhosis(n=10) by using western ligand blot(WLB) and radioimmunoassay(RIA). Serum IGFBP-3 level was significantly decreased in hepatoma and liver cirrhosis. Mean serum IGFBP-3
level
was
2443(±1258)ng/ml in hepatoma, 1308(±381)ng/ml in liver cirrhosis, and 4706(±519)ng/ml in healthy subject. There was a discrepancy of IGFBP-3 levels, as determined by RIA and WLB. This discrepancy can be explained by IGFB-3 protease activity,
which
was found in serum from some hepatoma but not from liver cirrhosis. We also observed the decreased level of serum IGFBP-2 in both groups. Serum IGFBP-1 and -4 were decreased in only liver cirrhosis.
We speculate the alteration of IGFBPs pattern in hepatoma would be due to decreased hepatic synthesis of IGFBPs, especially IGFBP-3 and serum IGFBP-3 protease activity, and the role of serum IGFBPs should be further studied.
키워드
원문 및 링크아웃 정보
등재저널 정보